SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001367644-17-000048
Filing Date
2017-11-03
Accepted
2017-11-03 12:25:00
Documents
56
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q092017.htm 10-Q 1000887
2 ex12.htm EX-12 54916
3 exhibit31_1.htm EX-31 12936
4 exhibit31_2.htm EX-31 12933
5 exhibit32_1.htm EX-32 3376
6 exhibit32_2.htm EX-32 3325
7 exhibit10_2.htm EX-10.2 50701
  Complete submission text file 0001367644-17-000048.txt   4671041

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT ebs-20170930.xml EX-101.INS 660769
9 XBRL TAXONOMY EXTENSION SCHEMA ebs-20170930.xsd EX-101.SCH 41009
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ebs-20170930_cal.xml EX-101.CAL 91524
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ebs-20170930_def.xml EX-101.DEF 202495
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE ebs-20170930_lab.xml EX-101.LAB 668601
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ebs-20170930_pre.xml EX-101.PRE 363694
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33137 | Film No.: 171175416
SIC: 2834 Pharmaceutical Preparations